SAB BIOTHERAPEUTICS, INC. Preferred Stock, Shares Outstanding
SAB BIOTHERAPEUTICS, INC. (SABS) had Preferred Stock, Shares Outstanding of 42.02 thousand shares as of 2025-06-30, per its 10-Q filed 2025-08-07.
Financial Statements › Balance Sheet › Equity › Stockholders' Equity, Number of Shares, Par Value and Other Disclosure › Preferred Stock, Number of Shares, Par Value and Other Disclosure
us-gaap:PreferredStockSharesOutstanding · last filed 2025-08-07
- 2025-06-30: Preferred Stock, Shares Outstanding 42.02K shares.
- 2025-03-31: Preferred Stock, Shares Outstanding 42.02K shares.
- 2024-12-31: Preferred Stock, Shares Outstanding 42.02K shares.
- 2024-09-30: Preferred Stock, Shares Outstanding 42.24K shares.
| Period end | Preferred Stock, Shares Outstanding | Preferred Stock, Shares Outstanding as first filed |
|---|---|---|
| 2025-06-30 | 42.02K shares 10-Q · filed 2025-08-07 | |
| 2025-03-31 | 42.02K shares 10-Q · filed 2025-05-09 | |
| 2024-12-31 | 42.02K shares 10-Q · filed 2025-08-07 | |
| 2024-09-30 | 42.24K shares 10-Q · filed 2024-11-06 | |
| 2024-06-30 | 42.24K shares 10-Q · filed 2024-08-08 | |
| 2024-03-31 | 42.24K shares 10-Q · filed 2024-05-20 | |
| 2023-12-31 | 42.24K shares 10-K · filed 2025-03-31 | |
| 2023-09-30 | 0.00 shares 10-Q · filed 2023-11-13 | |
| 2023-06-30 | 0.00 shares 10-Q · filed 2023-08-21 | |
| 2023-03-31 | 0.00 shares 10-Q · filed 2023-05-15 | |
| 2022-12-31 | 0.00 shares 10-K · filed 2024-03-29 | |
| 2022-09-30 | 0.00 shares 10-Q · filed 2022-11-14 | |
| 2022-06-30 | 10.00M shares 10-K · filed 2023-04-14 | 0.00 shares 10-Q · filed 2022-08-10 |
| 2022-03-31 | 10.00M shares 10-K · filed 2023-04-14 | 0.00 shares 10-Q · filed 2022-05-12 |
| 2021-12-31 | 0.00 shares 10-K/A · filed 2023-04-28 | |
| 2021-10-21 | 17.75M shares 10-K/A · filed 2023-04-28 | |
| 2021-09-30 | 0.00 shares 10-Q · filed 2021-11-22 | |
| 2021-06-30 | 0.00 shares 10-Q · filed 2021-08-09 | |
| 2020-12-31 | 0.00 shares 10-K/A · filed 2023-04-28 | |
| 2019-09-30 | 8.00M shares 10-Q · filed 2022-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Century Therapeutics, Inc. (IPSC) | United States | $0.306B | -4.02 |
| X4 Pharmaceuticals, Inc (XFOR) | United States | $0.297B | -4.99 |
| Inhibikase Therapeutics, Inc. (IKT) | United States | $0.296B | -4.44 |
| Liminatus Pharma, Inc. (LIMN) | United States | $0.282B | |
| FATE THERAPEUTICS INC (FATE) | United States | $0.280B | -2.51 |
| Lexeo Therapeutics, Inc. (LXEO) | United States | $0.278B | -4.19 |
| PALISADE BIO, INC. (PALI) | United States | $0.275B | -11.41 |
| Invivyd, Inc. (IVVD) | United States | $0.270B | -2.42 |
| Ocugen, Inc. (OCGN) | United States | $0.343B | -6.34 |
| SUTRO BIOPHARMA, INC. (STRO) | United States | $0.260B | -3.05 |